mazindol has been researched along with Mental Disorders in 1 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
Mental Disorders: Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fitzgerald, ML | 1 |
| Kassir, SA | 1 |
| Underwood, MD | 1 |
| Bakalian, MJ | 1 |
| Mann, JJ | 1 |
| Arango, V | 1 |
1 other study available for mazindol and Mental Disorders
| Article | Year |
|---|---|
Dysregulation of Striatal Dopamine Receptor Binding in Suicide.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Autoradiography; Benzazepines; Dopamine Agents; Dopamine | 2017 |